Unjha Formulations Ltd
₹0.00▲ +0.00 (+0.00%)
531762·NSE·Healthcare
Market Cap
10.70 Cr
PE Ratio
15.20
Volume
—
Day High - Low
—
52W High-Low
27.89 - 17.52
₹0.00▲ +0.00 (+0.00%)
Market Cap10.70 Cr
PE Ratio15.20
Volume—
Day High - Low—
52W High-Low27.89 - 17.52
Unjha Formulations Ltd (531762): company summary
Unjha Formulations Ltd (531762) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
Unjha Formulations Ltd (531762) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 5.8% a year over three years; profit grew 35.1% a year, ahead of revenue — margins are expanding. Return on equity is 20.1%.
- Valuation multiples
- The stock trades at 15.2 times earnings, a discount to the Healthcare median of 32.5, 2.79 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.4/10
Fair
Fair Value
Sign in to see
ROE
20.10%
Strong
P/E
15.20x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
52W₹17.52
₹27.89
DocStoX take
Supported by growth (8.0) and quality (6.3), but weakest on risk (5.0). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.4
/10
Fair
Quality
Solid
ROE 20.1%
Valuation
Fair
P/E 15.2×
Growth
Strong
Revenue +9.4% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹11 Cr
52W High / Low
₹28 / ₹18
Dividend Yield
0.00%
Promoter Holding
36.92%
EPS (TTM)
₹0.92
Book Value
₹8.57
Key highlights
- Profit compounding 47% a year
- Low leverage — D/E 0.00
- Profitable in all of the last 5 years
- Small ₹11 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Unjha Formulations Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Unjha Formulations Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Unjha Formulations Ltd with peers
Related tools & concepts
Value Unjha Formulations Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing